Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded
- Contract number
- SPE2DB26FAAF2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,015
Award facts
- Contract value 100% obligated
- $49,014.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $49,014.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of XGEVA 120 mg/1.7 mL vials. This is a non-set-aside contract with performance scheduled to conclude by October 21, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical vendor for federal medical procurement through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. The company's federal contracting history demonstrates capability across a wide spectrum of pharmaceutical products and medical supplies supporting military and veteran healthcare systems, including specialty medications, vaccines, and medical devices. This specific delivery order for XGEVA, an oncology therapeutic agent, reflects the company's ongoing role in supplying specialized pharmaceutical commodities to support the Defense Health Agency and broader military medical supply chain requirements.
Quick answers
Who was awarded contract SPE2DB26FAAF2?
SPE2DB26FAAF2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DB26FAAF2 worth?
The government has obligated $49,015 on SPE2DB26FAAF2.
Is contract SPE2DB26FAAF2 an order under another contract?
Yes. SPE2DB26FAAF2 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB26FAAF2 competed?
The extent of competition for SPE2DB26FAAF2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award